Clinical Trial Update: N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating N-acetylcysteine after Kasai Portoenterostomy for biliary atresia has completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Biliary Atresia | Phase 2 | Status: COMPLETED | Results posted: 2024-01-10